Opinion: Top 2 takeaways from UBS Global Healthcare Conference
The conference raised important points about unregulated growth opportunities and new pharmacy arena players.
Opinion: Top 2 takeaways from Asembia Specialty Pharmacy Summit
The conference raised important points about value-based contracts and the specialty pharmacy space.
Value-based care takes over J.P. Morgan Healthcare Conference 2017
Is the drive to value-based care really accelerating? What can be done amidst all of the uncertainty? Expert shares insights from the J.P. Morgan 35th Annual Healthcare Conference.
Three issues to watch at the J.P. Morgan Healthcare Conference 2017
This year’s J.P. Morgan Healthcare Conference will address some of the biggest managed care trends, including next-gen at-risk contracts and access to therapy as cancer trends towards a chronic condition.
What billions in lost pharma revenue means for managed care
Pharmaceutical manufacturer relationships and next-gen value based contracts are primed to accelerate value-derivation from your drug spend.
Real-world results determine value-based price for specialty drugs
In an era when adherence to specialty pharmaceuticals is disturbingly low, value-based pricing needs real-world results, not single-arm accelerated trials.
Four critical components for successful, value-based pharma contracts
Despite their proliferation, at-risk pharma contracts are still little more than value-based window dressing. Here are four critical components of contracts that can actually move the value meter in the right direction.
Opinion: Top 4 lessons learned from Asembia 2016
Insights from the 2016 edition of the largest gathering in specialty pharmacy.
Are your prior auth provisions stifling medication adherence?
Prior authorizations are here to stay. Are yours working against you? Find out.
How to make value-based care more valuable
Here are the top 3 value-based healthcare developments of 2015 and the top 3 ways to advance value-based care in 2016.
Five ways to improve patient medication adherence
Here are five ways healthcare organizations of all types, including managed care organizations, can improve patient adherence to prescribed medication therapies.
Four ways clinical pharmacists can improve managed care
Here are four reasons a clinical pharmacist should be part of care teams for chronically-ill, elderly, and at-risk patient populations.
2 Clarke Drive Cranbury, NJ 08512